LOQTORZI (toripalimab-tpzi)

**Product type:** Human Prescription Drug

**Active ingredient:** TORIPALIMAB

**Strength:** 240 mg/6mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Coherus Oncology, Inc.

**Marketing category:** BLA (BLA761240)

**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]